Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Privacy Policy  
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Chronic recurrent cystitis or transitional cell carcinoma - the differentiation
Transitional cell carcinoma (TCC) is the most common urinary tract tumor in dogs and research suggests that it may becoming more common. Often TCC is misdiagnosed as a chronic cystitis - unfortunately the tumors tend to be secondary infected. This article gives an excellent summary about the diagnosis of TCC including a new urine screening test.

Generally, TCC occurs in older dogs (mean age 11 years) and it occurs in females more frequently than in males. The increasing incidence of TCC may be related to pet obesity, use of topical pesticides for fleas/ticks, or environmental pollutants. (Mutsaers AJ, Widmer WR, Knapp DW. Transitional Cell Carcinoma. J Vet Intern Med 2003: 136-144).

Urinary tract tumors should be considered in any dog with hematuria, stranguria or polakyuria that does not rapidly and completely respond to appropriate antibiotic therapy.

Secondary urinary tract infections are common with TCC. The veterinarian should not exclude TCC from the rule-out list based on a positive urine culture or an improvement in clinical signs while on antibiotics.

The other rule-outs for recurring hematuria or dysuria include urinary calculi, resistant infections, anatomic defects, tumors other than TCC and rarely foreign bodies.

Initial evaluation for hematuria/dysuria should include: urinalysis, urine culture, rectal palpation to evaluate urethra/prostate and abdominal radiographs. Further evaluation might include CBC/chemistries, abdominal ultrasound, contrast studies, cystoscopy/vaginoscopy or surgery.

Urine screening test
A new urine screening test for transitional cell carcinoma is now also available (V-BTA test; Polymedco Inc; Redmond, Wash.) The test is a latex agglutination assay for glycoproteins released from the basement membrane of the bladder affected by cancer. The test has a sensitivity of 90 percent and a specificity of 78 percent. Interference with the test (causing false positives) occurs with marked glucosuria (4+), heavy proteinuria (4+) or pyuria/hematuria (>30-40 WBC or RBC/hpf). Therefore a negative test has an accurate negative predictive value of 95 percent, but a positive test result would mean that further evaluation is indicated to rule-in or rule-out neoplasia.

Definitive diagnosis of TCC requires a histopathologic evaluation of tissue collected by catheter biopsy (usually ultrasound-guided), cystoscopy or cystotomy. Ultrasound also provides information regarding possible metastasis to lymph nodes or other organs, and provides information regarding possible surgical resection of the tumor.

If ultrasound is not available, or of limited usefulness due to tumor mineralization or distal uretheral involvement, contrast cystourethrogram is indicated. TCC most commonly affects the trigone of the bladder and therefore curative surgical resection is often not possible due to ureter involvement. Therefore, understanding anatomic involvement prior to surgery is very useful for therapy and prognosis.

Source: Lisa Ann Dzyban (2004): Recurring cystitis or something else? In: DVM Newsmagazine Jun 1, 2004
www.dvmnewsmagazine.com/dvm/



Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Radioactive iodine uptake in hyperthyroid cats after rh-TSHmembers
Radioactive iodine therapy is considered the treatment of choice for hyperthyroidism in cats, but the availability of this modality is limited by costs and hospitalization requirements. Administration of recombinant human thyroid stimulating hormone (rh‐TSH) to humans with thyroid neoplasia or nodular goiter can increase thyroidal iodine uptake, thereby allowing the use of lower radioactive iodine doses for treatment. Veterinary studies of this subject are limited, and results are conflicting. Thus, the objective of this study was to investigate the effects of rh‐TSH administration on thyroidal iodine uptake in hyperthyroid cats.

  • Hypoechoic tissue changes in dogs with malignant prostatic lymphomamembers
  • Emphysematous gastritis in dogs and catsmembers
  • Primary pulmonary histiocytic sarcoma in dogsmembers
  • Determining prognosis in canine sepsis members
  • Correlation of plasma and tear glucose, creatinine and urea nitrogen in catsmembers
  • Perineal hernias in dogs - always a bilateral problem?members
  • Pharmacokinetic of gabapentin in catsmembers
  • Follicular development of canine ovaries stimulated by eCG plus hCGmembers
  • Gastrointestinal effects following acupuncture in healthy dogsmembers
  • Bilateral repair of apparently unilateral perineal hernias in dogsmembers
  • Retinal morphology of canine sudden acquired retinal degeneration syndromemembers
  • Sulfur hexafluoride microbubbles to improve ocular sonography in birdsmembers


  • [ Home ] [ About ] [ Contact / Request ] [ Privacy Policy ]

    Copyright © 2001-2018 VetContact GmbH
    All rights reserved